Increased plasma levels of ED1+ cellular fibronectin precede the clinical signs of preeclampsia.
about
Immune thrombocytopenia in pregnancyIntraocular and plasma levels of cellular fibronectin in patients with uveitis and diabetes mellitusMarkers for presymptomatic prediction of preeclampsia and intrauterine growth restriction.Endothelial microparticles and the antiangiogenic state in preeclampsia and the postpartum periodCellular fibronectin response to supervised moderate aerobic training in patients with type 2 diabetes.Evidence of endothelial dysfunction in preeclampsia and risk of adverse pregnancy outcome.Correlations between plasma levels of a fibronectin isoform subpopulation and C-reactive protein in patients with systemic inflammatory disease.Prediction of preeclampsia-bench to bedside.Identification of potential crucial genes associated with early-onset pre-eclampsia via a microarray analysis.Endothelial dysfunction in preeclampsia. Part I: Primary prevention. Therapeutic perspectives.Sera from preeclamptic women specifically activate human umbilical vein endothelial cells in vitro: morphological and biochemical evidence.Markers for endothelial injury, clotting and platelet activation in preeclampsia.Placental cytokines and the pathogenesis of preeclampsia.Hemodynamically-directed atenolol therapy is associated with a blunted rise in maternal sFLT-1 levels during pregnancy.Catalase activity, serum trace element and heavy metal concentrations, and vitamin A, D and E levels in pre-eclampsia.Thrombomodulin, plasminogen activator inhibitor type 1 (PAI-1) and fibronectin as biomarkers of endothelial damage in preeclampsia and eclampsia.Pre-eclampsia outcomes in different hemodynamic models.
P2860
Q33387170-9A4F7479-66F5-449F-84EF-7D24C574CB54Q35592023-90F78F39-795B-4AE1-9DD9-7254E92DEBC1Q35888435-51524A44-DC69-427B-9E29-06589097CAA3Q36204238-A0C1BC3B-E274-4A2A-BD70-E853C7DFF57EQ36904398-CB57E3BD-5DB5-44E4-9C58-269358604A27Q37177940-9A9BFB04-F970-4435-9A2F-4C6F17B2B168Q37351728-56682843-6802-4FAA-ADA1-994B30759AF7Q38252740-C9A990B7-ABC6-43BE-82B9-EF1295B65634Q38430542-1C22E3CF-D811-4BE5-BADE-3FC95F48B58AQ40959095-7A41CB62-D38D-433B-9D12-37026F9B7B67Q41098649-46178434-ED10-4231-B666-E1565B3F7AF7Q41123502-6DBDEC55-8160-4702-B238-D9C2281F84FDQ41452017-4EF78D36-08BD-432E-BB3D-E06368770535Q46150310-28B10F66-BDD9-4090-B6A2-194FDC510D76Q46191459-A753D023-3952-41BD-8280-463CF9A1E6F9Q46305789-21C4DDCB-1A0F-478B-98C7-D4897B19604FQ46336679-50D80F09-27C6-408E-BA86-F0BC9148F07F
P2860
Increased plasma levels of ED1+ cellular fibronectin precede the clinical signs of preeclampsia.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Increased plasma levels of ED1 ...... linical signs of preeclampsia.
@en
type
label
Increased plasma levels of ED1 ...... linical signs of preeclampsia.
@en
prefLabel
Increased plasma levels of ED1 ...... linical signs of preeclampsia.
@en
P1476
Increased plasma levels of ED1 ...... linical signs of preeclampsia.
@en
P2093
Lockwood CJ
P304
P356
10.1016/0002-9378(90)90385-K
P407
P577
1990-02-01T00:00:00Z